Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test
- PMID: 12795734
- PMCID: PMC1494867
- DOI: 10.1046/j.1525-1497.2003.20525.x
Physician and patient factors associated with ordering a colon evaluation after a positive fecal occult blood test
Abstract
Objective: Successful colorectal cancer screening relies in part on physicians ordering a complete diagnostic evaluation of the colon (CDE) with colonoscopy or barium enema plus sigmoidoscopy after a positive screening fecal occult blood test (FOBT).
Design: We surveyed primary care physicians about colorectal cancer screening practices, beliefs, and intentions. At least 1 physician responded in 318 of 413 (77%) primary care practices that were affiliated with a managed care organization offering a mailed FOBT program for patients aged >/=50 years. Of these 318 practices, 212 (67%) had 602 FOBT+ patients from August through November 1998. We studied 184 (87%) of these 212 practices with 490 FOBT+ patients after excluding those judged ineligible for a CDE or without demographic data. Three months after notification of the FOBT+ result, physicians were asked on audit forms if they had ordered CDEs for study patients. Patient- and physician-predictors of ordering CDEs were identified using logistic regression.
Measurements and main results: A CDE was ordered for only 69.5% of 490 FOBT+ patients. After adjustment, women were less likely to have had CDE initiated than men (adjusted odds, 0.66; confidence interval, 0.44 to 0.97). Physician survey responses indicating intermediate or high intention to evaluate a FOBT+ patient with a CDE were associated with nearly 2-fold greater adjusted odds of actually initiating a CDE in this circumstance versus physicians with a low intention.
Conclusions: Primary care physicians often fail to order CDE for FOBT+ patients. A CDE was less likely to be ordered for women and was influenced by physician's beliefs about CDEs.
Comment in
-
Patient-provider communication in cancer screening.J Gen Intern Med. 2003 May;18(5):402-3. doi: 10.1046/j.1525-1497.2003.30346.x. J Gen Intern Med. 2003. PMID: 12795740 Free PMC article. No abstract available.
Similar articles
-
Physician intention to recommend complete diagnostic evaluation in colorectal cancer screening.Cancer Epidemiol Biomarkers Prev. 1999 Jul;8(7):587-93. Cancer Epidemiol Biomarkers Prev. 1999. PMID: 10428195
-
Complete diagnostic evaluation in colorectal cancer screening: research design and baseline findings.Prev Med. 2001 Oct;33(4):249-60. doi: 10.1006/pmed.2001.0878. Prev Med. 2001. PMID: 11570828 Clinical Trial.
-
Effectiveness of complete diagnostic examination in clinical practice settings.Cancer Detect Prev. 2006;30(6):545-51. doi: 10.1016/j.cdp.2006.10.001. Epub 2006 Nov 17. Cancer Detect Prev. 2006. PMID: 17113240 Free PMC article.
-
Colorectal cancer screening.Prim Care. 1999 Mar;26(1):179-87. doi: 10.1016/s0095-4543(05)70108-1. Prim Care. 1999. PMID: 9922301 Review.
-
The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis.United European Gastroenterol J. 2019 Apr;7(3):424-448. doi: 10.1177/2050640619828185. Epub 2019 Feb 6. United European Gastroenterol J. 2019. PMID: 31019712 Free PMC article.
Cited by
-
Diagnostic work-up of rectal bleeding in general practice.Br J Gen Pract. 2005 Jan;55(510):14-9; discussion 18. Br J Gen Pract. 2005. PMID: 15667760 Free PMC article.
-
Strategies for expanding colorectal cancer screening at community health centers.CA Cancer J Clin. 2013 Jul-Aug;63(4):221-31. doi: 10.3322/caac.21191. CA Cancer J Clin. 2013. PMID: 23818334 Free PMC article.
-
Repeated Automated Mobile Text Messaging Reminders for Follow-Up of Positive Fecal Occult Blood Tests: Randomized Controlled Trial.JMIR Mhealth Uhealth. 2019 Feb 5;7(2):e11114. doi: 10.2196/11114. JMIR Mhealth Uhealth. 2019. PMID: 30720439 Free PMC article.
-
Classification tree analysis to enhance targeting for follow-up exam of colorectal cancer screening.BMC Cancer. 2013 Oct 10;13:470. doi: 10.1186/1471-2407-13-470. BMC Cancer. 2013. PMID: 24112563 Free PMC article.
-
Using a multifaceted approach to improve the follow-up of positive fecal occult blood test results.Am J Gastroenterol. 2009 Apr;104(4):942-52. doi: 10.1038/ajg.2009.55. Epub 2009 Mar 17. Am J Gastroenterol. 2009. PMID: 19293786 Free PMC article.
References
-
- Centers for Disease Control and Prevention. CDC WONDER Compressed Mortality Database 1999. Available at: http://wonder.cdc.gov/mortSQL.shtml. Accessed April 23, 2003.
-
- Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomized controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet. 1996;348:1472–7. - PubMed
-
- Kronborg O, Fenger C, Olsen J, Jorgensen OD, Sondergaard O. Randomized study of screening for colorectal cancer with fecal-occult-blood test. Lancet. 1996;348:1467–71. - PubMed
-
- Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota Colon Cancer Control Study. N Engl J Med. 1993;328:1365–71. - PubMed
-
- Mandel JS, Church TR, Bond JH, et al. The effect of fecal occult blood screening on the incidence of colorectal cancer. N Engl J Med. 2000;343:1603–7. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical